When you should not travel to India for treatment

We arrange medical travel to India. We also advise a meaningful share of the patients who approach us not to come. Those two facts sit uncomfortably together in a business, which is roughly why almost nobody publishes the second one.

What follows are the situations in which our panel most often concludes that a patient is better off staying where they are. If any of them describes you, that is worth knowing before you spend money on a facilitator — including us.

1. The condition is unstable or genuinely time-critical

Medical travel has a minimum lead time. Records review, a quote, a visa, flights, and admission scheduling do not compress below a few weeks even when everything goes smoothly. A condition that needs intervention in days does not survive that timeline.

There is a harder version of this problem. Some conditions are stable enough to plan around today and will not be in six weeks. Assessing that is a clinical judgement, not a logistical one, and it is the single most common reason our reviewers advise against travel.

2. The treatment needs long-term follow-up that cannot happen at home

A knee replacement is largely finished when you walk out. A course of chemotherapy, an immunosuppression regimen after transplant, or a device requiring regular interrogation is not — it is the beginning of a relationship with a clinical service that has to exist somewhere near you.

Before travelling for anything with a long tail, establish concretely who at home will manage it. Not "my GP probably will." A named clinician who has agreed. If nobody will take it on, the treatment abroad may be technically successful and still go badly.

3. The complication risk makes the return flight unsafe

Long-haul flight after major surgery carries real risk, most obviously venous thromboembolism, and the window in which flying is inadvisable varies by procedure and by patient. Guidance from aviation medicine bodies and national health services is specific about minimum intervals after certain operations, and it is longer than most patients assume.^[1][2]

Where the realistic complication rate is high, the calculation changes further. A complication managed in the hospital that caused it is an inconvenience. The same complication presenting three days after you land at home, to a team with no operative notes and no relationship with the surgeon, is a different event.

4. You can get the same procedure at home within a clinically acceptable time

Waiting lists are a genuine driver of medical travel, particularly from the UK and Canada. But "waiting" and "waiting too long" are different things. For many elective procedures a wait of some months carries no measurable harm; for others, deterioration during the wait changes the outcome.

The right question is not "how long is the wait?" It is "what happens to me during that wait?" Ask your own specialist directly. If the honest answer is that a few months makes no clinical difference, the case for travelling weakens considerably.

5. The saving is small relative to the risk you are taking on

The cost gap between India and high-income health systems is real and, for major surgery, large. For smaller procedures it often is not — once international airfare, accommodation for you and a companion, visa costs, time away from work, and the possibility of an extended stay are counted, the gap can close substantially.

A rule of thumb we apply internally: if the all-in saving does not comfortably exceed the cost of the entire trip repeated once, the margin is too thin to justify carrying the additional risk of being treated far from home.

6. You would be travelling alone

Post-operative patients need an advocate. Someone to notice that you are not right, to ask the question you are too unwell to ask, to hold the discharge summary, and to make decisions if you cannot. Hospitals are staffed; they are not a substitute for a person whose only job is you.

If you cannot travel with a companion, and cannot arrange for one to join you for the admission period, we generally advise against major surgery abroad. This is a practical objection rather than a clinical one, but in our experience it predicts bad experiences as reliably as any clinical factor.

7. What you actually want is a different diagnosis

Some people approach medical travel after a diagnosis they have not been able to accept. The hope, not always conscious, is that a different country will produce a different answer.

Sometimes it does — reasonable specialists do disagree, and that is precisely why second opinions exist. But a second opinion is the right tool for that question, and it costs a hundred dollars rather than several thousand. Fly because a treatment decision has been made. Do not fly in order to make one.

How often do we actually say no?

We publish it. Each quarter we report the share of reviewed international cases in which our panel advised the patient against travelling to India, alongside the number of cases that figure is drawn from.

We do this for a simple reason. A facilitator's incentive runs one way: they are paid when you travel. Any advice from one that never resolves against travel should be read as marketing. Publishing the number is the only way we can think of to make our advice checkable rather than merely asserted.

See the current figure →

If none of this applies to you

Then medical travel may well be a reasonable decision, and the things to get right are unglamorous: a binding price rather than an estimate, a named person who meets you at the airport, a discharge pack your own doctor can use, and a written answer to the question of who pays if the cost overruns. We have written separately about what to ask any facilitator about cost overruns.